Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

By F. Castro, A. P. Cardoso, R. Gonçalves, K. Serre, M. Oliveira. Frontiers in Immunology, 2018

1,085 citations recorded by the source corpus.

Interferon-gamma (IFN-γ) is a pleiotropic molecule with associated antiproliferative, pro-apoptotic and antitumor mechanisms. This effector cytokine, often considered as a major effector of immunity, has been used in the treatment of several diseases, despite its adverse effects. Although broad evidence implicating IFN-γ in tumor immune surveillance, IFN-γ-based therapies undergoing clinical trials have been of limited success. In fact, recent reports suggested that it may also play a protumorigenic role, namely, through IFN-γ signaling insensitivity, downregulation of major histocompatibility complexes, and upregulation of indoleamine 2,3-dioxygenase and of checkpoint inhibitors, as programmed cell-death ligand 1. However, the IFN-γ-mediated responses are still positively associated with patient’s survival in several cancers. Consequently, major research efforts are required to understand the immune contexture in which IFN-γ induces its intricate and highly regulated effects in the tumor microenvironment. This review discusses the current knowledge on the pro- and antitumorigenic effects of IFN-γ as part of the complex immune response to cancer, highlighting the relevance to identify IFN-γ responsive patients for the improvement of therapies that exploit associated signaling pathways.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/e3a2a41ae27e926430c1277881297cd4b01bedf1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Y. Shiravand
  2. R. Ladwa
  3. K. O'Byrne
  4. S. R. Hosseini-Fard
  5. Faezeh Khodadadi
  6. Seyyed Mohammad Amin Kashani
  7. H. Sadeghirad
  8. Shadi Hosseini

Citations in the corpus